Villy Valcheva
Net worth: - $ as of 2026-07-30
Net worth: - $ as of 2026-07-30
Velichka Valcheva is currently Chief Executive Officer at GH Research Plc since 2024.
Formerly, Dr. Valcheva was VP & Head-International Medical Affairs at Albireo Pharma, Inc. from 2020 to 2023 and Global Senior Medical Director-Oncology at Ipsen Pharma SAS from 2018 to 2020.
Education includes a doctorate from Medical University of Plovdiv and a graduate degree from Trinity College Dublin.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GH RESEARCH PLC -.--% | 2026-03-17 | 0 ( -.--% ) | - $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| GH RESEARCH PLC | Chief Executive Officer | 2024-09-02 |
| Companies | Position | End |
|---|---|---|
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 2022-12-31 |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2019-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Trinity College Dublin
Trinity College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Medical University of Plovdiv
Medical University of Plovdiv Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GH Research Plc
GH Research Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapies for the management of psychiatric and neurological disorders | Health Technology |
Select your edition
All financial news and data tailored to specific country editions